Publications by authors named "Ryuichi Noguchi"

Claim this Profile
F
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis.
Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Akihiko Shibamoto, Takahiro Kubo, Ryuichi Noguchi

Hepatol Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
Yuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, Naoki Nishimura, Ryuichi Noguchi

Dig Dis Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma.
Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, Hiroki Kinoshita, Naoki Nishimura, Ryuichi Noguchi

JGH Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis.
Takuya Matsuda, Tadashi Namisaki, Akihiko Shibamoto, Shohei Asada, Fumimasa Tomooka, Ryuichi Noguchi

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonic gallstone ileus treated by a transanal ileus tube followed by spontaneous gallstone dislodgement: A case report.
Tadataka Takagi, Shoichi Kinoshita, Chihiro Kawaguchi, Kuniyuki Kojima, Hirotsugu Ueno, Ryuichi Noguchi

DEN Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Junya Suzuki, Koji Murata, Ryuichi Noguchi

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
Tadashi Namisaki, Kosuke Kaji, Naotaka Shimozato, Daisuke Kaya, Takahiro Ozutsumi, Ryuichi Noguchi

Indian J Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case report.
Misako Tanaka, Hideto Kawaratani, Ryuichi Noguchi, Aritoshi Koizumi, Akihiko Shibamoto

BMC Gastroenterol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa and VIVA Systems.
Hiroaki Takaya, Tadashi Namisaki, Kazusuke Matsumoto, Junya Suzuki, Koji Murata, Ryuichi Noguchi

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, Kosuke Kaji, Haruna Miyakawa

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis.
Yukihisa Fujinaga, Tadashi Namisaki, Hiroaki Takaya, Yuki Tsuji, Junya Suzuki, Ryuichi Noguchi

Medicine (Baltimore)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of refractory and severe duodenal ulcers associated with olmesartan.
Kei Moriya, Kuniyuki Kojima, Hideto Kawaratani, Ryuichi Noguchi, Hitoshi Yoshiji

Gastrointest Endosc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Ryuichi Noguchi, Kosuke Kaji, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani

Mol Med Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.
Yuki Tsuji, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Keisuke Nakanishi, Ryuichi Noguchi

Exp Ther Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2'-deoxycytidine in Hepatic Stellate Cells.
Kiyoshi Asada, Kosuke Kaji, Shinya Sato, Kenichiro Seki, Naotaka Shimozato, Ryuichi Noguchi

Biology (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneously ruptured hepatocellular carcinoma in Fontan-associated liver disease: A case report.
Takahiro Kubo, Yosuke Aihara, Hideto Kawaratani, Tadashi Namisaki, Ryuichi Noguchi

SAGE Open Med Case Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Takahiro Ozutsumi, Tadashi Namisaki, Naotaka Shimozato, Kosuke Kaji, Yuki Tsuji, Ryuichi Noguchi

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Kosuke Kaji, Keisuke Nakanishi, Ryuichi Noguchi

BMC Gastroenterol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients.
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Naotaka Shimozato, Kosuke Kaji, Ryuichi Noguchi

World J Gastrointest Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of clinical risk factors for histological progression of primary biliary cholangitis.
Yukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Hideto Kawaratani, Ryuichi Noguchi

Hepatol Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Short-term sustained virological response in a patient with liver cirrhosis, hepatitis C, and declining hepatic spare ability during treatment with direct-acting antivirals].
Hitoshi Mori, Hiroaki Takaya, Tadashi Namisaki, Ryuichi Noguchi, Junichi Hanatani

Nihon Shokakibyo Gakkai Zasshi· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.
Kosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, Kei Moriya, Takemi Akahane

Exp Ther Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.
Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Takeda, Kosuke Kaji, Ryuichi Noguchi

Hepatol Commun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Ryuichi Noguchi

Oncol Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
Ryuichi Noguchi, Kosuke Kaji, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade

World J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis